Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study
Keywords:
injecting drug users, mucocutaneous lesions, dermatology quality of life index, DASS score, track marksAbstract
Introduction: Drug abuse has been taking a great toll on the health and well-being of the community for the past few decades. Substance abuse can lead to several cutaneous manifestations both direct injury by the offending drug or the practices of drug usage causing secondary damage to the skin. The early recognition of these signs is of utmost importance to prevent long-term complications.
Objectives: To study the clinical-epidemiological profile of the skin diseases in Injecting Drug Users (IDU) attending Oral Substitution Therapy (OST) center and assess the psychological impact of skin conditions in IDUs attending oral substitution therapy center.
Methods: This cross-sectional observational study involved 100 IDUs enrolled from the OST center who were subjected to brief history taking and clinical and dermoscopic evaluation of skin lesions. Dermatological quality of life index (DLQI), Depression, Anxiety, Stress Scale (DASS), and WHO-QoL questionnaire were used to evaluate the impact of skin lesions on Psycho-social health and quality of life of IDUs.
Results: Cutaneous lesions ranged from track marks to severe ulcerations and scarring. Mucosal lesions also took a toll on several Patients. Patients had varying degrees of anxiety, depression, and mental stress.
Conclusions: Injecting Drug Abusers are prone to acquire Skin diseases due to injury caused by drugs as well as by drug practices adopted and the degree of neglect may worsen these conditions. These cutaneous lesions hamper the quality of life and cause psychosocial disturbances.
References
2. Pierce M, Hayhust K, Bird S M et al. Insights into link between drug use and criminality: Lifetime offending of criminally active opiate users. Drug Alcohol Depend.2017;179:309-306.
3. Gupta VK, Kaur P, Singh G, Kaur A, et al. A study of profile of patients admitted in the drug de-addiction centres in state of Punjab. Int J Res Health Sci.2013; vol 1: issue 2.
4. Fox TP, Oliver G, Ellis SM. The destructive capacity of drug abuse: an overview exploring the harmful potential of drug abuse both to the individual and society: ISRN Addiction.2013.10.1155.
5. Henning C, Miller J. Illicit drugs: what dermatologists need to know. J Am Acad Dermatol.2013;69:135-142.
6. Khalsa JH, Triesman G, McCance-Katz E, Tedaldi E. Medical consequences of abuse and co-occurring infections. Subst Abus.2008;29(3):5-16.
7. Del GP. Cutaneous complications of Intravenous Drug abuse. Br J Dermatol.2004;150:1-10.
8. Binswanger IA, Kral AH, Bluthenthal KN, Rybold DJ et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis.2000;30:579-581.
9. Olopoenia LA, Mody V, Reynolds M. Eiknella corrodens endocarditis in an intravenous drug user: a case report and literature review. J Natl Med Assoc.1994;86:313-5.
10. Cooper JG, Spike CE, Denton M, Jamieson S. Clostridium botulinum: an increasing complication of heroin misuse. Eur J Emer Med.2005;12:251-2.
11. Drug use and viral infections(HIV, Hepatitis) drug facts. National Institute on drug abuse.16 Jun2020. retrieved from internet www.drugabuse.gov/publications/drugfacts/druguse-viral-infections.
12. Altman K, Vanness E, Westergaard PR. Cutaneous manifestations of Human immune deficiency virus: a clinical update. Curr Infect Dis Rep.2015; 17(3):464.
13. Jones MA, Warken K, Tyring SK. The cutaneous manifestations of viral hepatitis. Dermatol Clin. 2002: Vol 20:Issue 2:233-47.
14. Pieper B, Kisrner RS, Templin TN, Birk TJ. Chronic venous disease and injection drug use. Arch Intern Med.2007:167:1807.
15. Somers WJ, Lowe FC. Localized gangrene of the scrotum and penis: a complication of heroin injection into the femoral vessels. J Urol.1986: 136:111-3.
16. White WB, Barrett S. Penile ulcer in heroin abuse: a case report. Cutis. 1982;29:62-69.
17. Georgiadis G, Bessias NC, Pavlidis PM et al. Infected false aneurysms of the limbs secondary to chronic intravenous drug abuse: analysis of perioperative considerations and operative outcomes. Surg Today.2007;37:837-844.
18. Kokovski L, Butany J, Nair V. Femoral artery pseudoaneurysm due to Candida albicans in an injection drug user. Cardiovasc Pathol.2014;25:50-3.
19. Smith ME, Robinowitz N, Chaulk P, Johnson KE. Selfcare and risk reduction habits in older injection drug users with chronic wounds: a cross-sectional study. Harm Reduct J.2014;11(1):28.
20. Elepern DJ. Cocaine abuse and delusions of parasitosis. Cutis.1988;42:273-4.
21. Degenhardt L, Peacock A, Colledge S. et al. Articles global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;12:1192-1207.
22. Liu SW, Lien MH, Fenske NA. The effects of alcohol and drug abuse on the skin. Clin Dermatol. 2010;28(4):391-9.
23. Brewer JD, Meves A, Bostwick JM, Hamacher KL, Pittelkow MR. Cocaine abuse: Dermatological manifestations and therapeutic approaches. J Am Acad Dermatol 2008; 59(3):483-7.
24. Chen SC. Dermatology Quality of Life instruments: sorting out the quagmire. J Invest Dermatol.2007;127:2695-6.
Published
Issue
Section
License
Copyright (c) 2022 Shaminder Singh Dhillon, Tejinder Kaur, Neeru Bala, none Mankaranpreet
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
